The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
benzyl 4-((trans-4-(3-(4-(trifluoromethoxy)phenyl)ureido)cyclohexyl)oxy)benzoate ID: ALA4215208
Chembl Id: CHEMBL4215208
PubChem CID: 130431481
Max Phase: Preclinical
Molecular Formula: C28H27F3N2O5
Molecular Weight: 528.53
Molecule Type: Small molecule
Associated Items:
Names and Identifiers Canonical SMILES: O=C(Nc1ccc(OC(F)(F)F)cc1)N[C@H]1CC[C@H](Oc2ccc(C(=O)OCc3ccccc3)cc2)CC1
Standard InChI: InChI=1S/C28H27F3N2O5/c29-28(30,31)38-25-16-10-22(11-17-25)33-27(35)32-21-8-14-24(15-9-21)37-23-12-6-20(7-13-23)26(34)36-18-19-4-2-1-3-5-19/h1-7,10-13,16-17,21,24H,8-9,14-15,18H2,(H2,32,33,35)/t21-,24-
Standard InChI Key: IEOQZCMTPHDRLT-SAIGFBBZSA-N
Associated Targets(Human) Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 528.53Molecular Weight (Monoisotopic): 528.1872AlogP: 6.45#Rotatable Bonds: 8Polar Surface Area: 85.89Molecular Species: NEUTRALHBA: 5HBD: 2#RO5 Violations: 2HBA (Lipinski): 7HBD (Lipinski): 2#RO5 Violations (Lipinski): 2CX Acidic pKa: 13.90CX Basic pKa: ┄CX LogP: 7.01CX LogD: 7.01Aromatic Rings: 3Heavy Atoms: 38QED Weighted: 0.33Np Likeness Score: -0.91
References 1. Kodani SD, Bhakta S, Hwang SH, Pakhomova S, Newcomer ME, Morisseau C, Hammock BD.. (2018) Identification and optimization of soluble epoxide hydrolase inhibitors with dual potency towards fatty acid amide hydrolase., 28 (4): [PMID:29366648 ] [10.1016/j.bmcl.2018.01.003 ]